Table 1 Characteristics and respective treatments of patients included for µ opioid receptor expression analysis in peripheral blood mononuclear cells.
| Disease status | Age (y) | Sex (F/M) | Clinical manifestations (n) | Therapeutic management (n) |
|---|---|---|---|---|
| Crohn's disease | 32 (9) | 17/7 | Ileal (7) | None (4) |
| Ileocolonic (11) | Immunosuppressors (16) | |||
| Colonic (6) | Steroids (2) | |||
| Aminosalicylics (2) | ||||
| Ulcerative colitis | 40 (10) | 4/12 | Colonic (16) | None (4) |
| Aminosalicylics (3) | ||||
| Steroids (4) | ||||
| Aminosalicylics and steroids (2) | ||||
| Immunosuppressors (3) | ||||
| Controls | 47 (14) | 13/10 | None (23) |